Search

Search Constraints

You searched for: Author/Creator Szecsödy, Peter

Search Results

1. Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial. (15th April 2020)

2. Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction. (26th July 2021)

3. Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial. (9th December 2021)

4. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial . (23rd August 2022)